| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 03/02/2004 | CA2003051C Delineation of individual human chromosomes in metaphase and interphase cells by in situ suppression hybridization |
| 02/29/2004 | WO2004016767A2 Evolving new molecular function |
| 02/29/2004 | CA2495881A1 Evolving new molecular function |
| 02/26/2004 | WO2004017068A1 Method of detecting nucleic acid by using dna microarrays and nucleic acid detection apparatus |
| 02/26/2004 | WO2004017062A1 The method and device for accelerating molecular hybridization by ultrasonic wave |
| 02/26/2004 | WO2004017057A1 Biosensor and method for manufacturing same |
| 02/26/2004 | WO2004017041A2 High resolution flow cytometer |
| 02/26/2004 | WO2004016814A1 Method of estimating drug metabolic activity by analyzing mutations in glucuronosyl transferase gene |
| 02/26/2004 | WO2004016813A2 Hnf1 alpha as a tumor suppressor gene, and diagnostic and therapeutic applications thereof |
| 02/26/2004 | WO2004016812A1 Avian sex determination method |
| 02/26/2004 | WO2004016809A1 Nucleic acid array comprising selective monocytic macrophagic genes |
| 02/26/2004 | WO2004016808A1 Method and apparatus for washing solid substrate with ultrasonic wave after hybridization reaction |
| 02/26/2004 | WO2004016807A1 Method for determining free thrombin concentration |
| 02/26/2004 | WO2004016806A1 Using a polymerase with 3' to 5' exonuclease activity to perform gene sequence analysis |
| 02/26/2004 | WO2004016805A2 Immunostimulatory nucleic acids |
| 02/26/2004 | WO2004016802A2 Methods and apparatus for preparing and assaying biological samples to determine protein concentration |
| 02/26/2004 | WO2004016800A2 Assay for low molecular weight heparin |
| 02/26/2004 | WO2004016795A1 Methods for inducing targeted stimulation of meiotic recombination and kits for performing said methods |
| 02/26/2004 | WO2004016792A1 Novel expression vector suitable for expression of recombinant protein at low temperature |
| 02/26/2004 | WO2004016790A1 Novel n-acetylgalactosamine transferases and nucleic acids encoding the same |
| 02/26/2004 | WO2004016785A1 Method of examining atopic dermatitis |
| 02/26/2004 | WO2004016784A1 Protease inhibitor |
| 02/26/2004 | WO2004016783A1 Method of examining atopic dermatitis |
| 02/26/2004 | WO2004016768A2 Compositions and methods for inferring ancestry |
| 02/26/2004 | WO2004016766A2 Real time measurement of cellular responses |
| 02/26/2004 | WO2004016765A2 Method for search based character optimization |
| 02/26/2004 | WO2004016764A2 eNOS MUTANTS USEFUL FOR GENE THERAPY |
| 02/26/2004 | WO2004016759A2 Compositions and methods for induction of proteins involved in xenobiotic metabolism |
| 02/26/2004 | WO2004016758A2 Brain endothelial cell expression patterns |
| 02/26/2004 | WO2004016757A2 Methods, compositions and kits for producing nucleic and acid sequences |
| 02/26/2004 | WO2004016755A2 Amplification of target nucleotide sequence without polymerase chain reaction |
| 02/26/2004 | WO2004016744A2 Treatment of liver deseases |
| 02/26/2004 | WO2004016742A2 α(1,3)-GALACTOSYLTRANSFERASE NULL CELLS, METHODS OF SELECTING AND α(1,3)-GALACTOSYLTRANSFERASE NULL SWINE PRODUCED THEREFROM |
| 02/26/2004 | WO2004016732A2 Astrocyte modulated genes and uses thereof |
| 02/26/2004 | WO2004016729A2 SYSTEMS AND METHODS FOR CONTROL OF pH AND OTHER REACTOR ENVIRONMENTAL CONDITIONS |
| 02/26/2004 | WO2004016727A1 Determination and/or control of reactor environmental conditions |
| 02/26/2004 | WO2004016726A2 Methods and compositions for extending the life span and increasing the stress resistance of cells and organisms |
| 02/26/2004 | WO2004016644A2 Compositions and methods used for identifying factors required for the agglomeration of proteins |
| 02/26/2004 | WO2004016639A1 Bmp-2 estrogen responsive element and methods of using the same |
| 02/26/2004 | WO2004016637A1 Gene families associated with liver cancer |
| 02/26/2004 | WO2004016317A1 Use of murine genomic regions identified to be involved in tumor development for the development of anti-cancer drugs and diagnosis of cancer |
| 02/26/2004 | WO2004016255A1 The use of resveratrol to regulate expression of apolipoprotein a1 |
| 02/26/2004 | WO2004016228A2 HTLV-I p30II AND p12I PROTEINS AS THERAPEUTIC TARGETS IN HTVL-I INFECTED INDIVIDUALS |
| 02/26/2004 | WO2004016227A2 Screening methods for cognitive enhancers |
| 02/26/2004 | WO2004016223A2 Assaying compounds or agents for microsomal prostaglandin e synthase or hematopoietic prostaglandin d synthase activity |
| 02/26/2004 | WO2004016222A2 Hepatitis c viral-like particle purification |
| 02/26/2004 | WO2004016220A2 Apicomplexan pathways, inhibitiors, and drug delivery |
| 02/26/2004 | WO2004016219A2 Clinical assays for the detection and typing of human herpesviruses |
| 02/26/2004 | WO2004016212A2 Methods and compositions for targeting secretory lysosomes |
| 02/26/2004 | WO2004016156A2 Dynamic hepatic recycling glucose tolerance test |
| 02/26/2004 | WO2004016154A2 Molecular lymphatic mapping of sentinel lymph nodes |
| 02/26/2004 | WO2004016082A1 Nonhuman model animal nonresponsive to endotoxin and lipoprotein or lipopeptide |
| 02/26/2004 | WO2004005548A3 A method for discovery of human genes associated with viral hepatitis infection |
| 02/26/2004 | WO2004001376A3 Apparatus for polynucleotide detection and quantitation |
| 02/26/2004 | WO2003106680B1 Method for amplifying rna, and its use in expression profiling |
| 02/26/2004 | WO2003102602A3 Dna sensor arrangement and method for measuring the impedance in a dna sensor arrangement |
| 02/26/2004 | WO2003102581A3 Assay for glycosylated proteins |
| 02/26/2004 | WO2003098223A3 A method for killing cells by inhibiting histone activity in the cell |
| 02/26/2004 | WO2003097859A3 Method for producing polymer layers |
| 02/26/2004 | WO2003095674A3 Methods for evaluating a disease condition by detection of particle and non-particle bound nucleic acids in blood plasma and serum |
| 02/26/2004 | WO2003094862A3 tRNA SYNTHASE: MODULATORS OF ANGIOGENESIS |
| 02/26/2004 | WO2003089589A3 Matrix analysis of gene expression in cells (magec) |
| 02/26/2004 | WO2003087841A3 An ephrin-b receptor protein involved in carcinoma |
| 02/26/2004 | WO2003087775A3 Monitoring blood substances using self-sampled tears |
| 02/26/2004 | WO2003087132A3 Compositions and methods for evaluating and designing nuclear receptor ligands that modulate co-regulator affinity |
| 02/26/2004 | WO2003084384A3 Diagnosis of flavivirus infection |
| 02/26/2004 | WO2003083489A9 System for performing blood coagulation assays and measuring blood clotting times |
| 02/26/2004 | WO2003083435A3 Single primer isothermal nucleic acid amplification-enhanced analyte detection and quantification |
| 02/26/2004 | WO2003083140A3 Classification and prognosis prediction of acute lymphoblasstic leukemia by gene expression profiling |
| 02/26/2004 | WO2003083050A3 Human deubiquitinating protease gene on chromosome 7 and its murine ortholog |
| 02/26/2004 | WO2003080000A3 Modulation of angiogenesis through targeting of cysteine oxygenase activity |
| 02/26/2004 | WO2003078651A3 Novel hmga alleles and use of the same as genetic markers for growth, fatness, meat quality and feed efficiency traits |
| 02/26/2004 | WO2003072758A3 Methods for designing oligo-probes with high hybridization efficiency and high antisense activity |
| 02/26/2004 | WO2003071270A3 Screening method |
| 02/26/2004 | WO2003070894A3 A non-invasive diagnostic test utilizing histone modification markers |
| 02/26/2004 | WO2003070700A3 Compositions and methods for determining the susceptibility of a pathogenic virus to protease inhibitors |
| 02/26/2004 | WO2003068979A9 System and methods for discriminating an agent |
| 02/26/2004 | WO2003068908A3 Cardiotoxin molecular toxicology modeling |
| 02/26/2004 | WO2003066813A3 MINRs AS MODIFIERS OF INSULIN RECEPTOR SIGNALING AND METHODS OF USE |
| 02/26/2004 | WO2003066812A3 Substituted 4,4-difluoro-4-bora-3a, 4a-diaza-s-indacene compounds for 8-color dna sequencing |
| 02/26/2004 | WO2003064999A3 Methods for identifying modulators of receptor tyrosine kinases |
| 02/26/2004 | WO2003064615A3 Amplifying repetitive nucleic acid sequences |
| 02/26/2004 | WO2003063765A3 Multi-disciplinary approach to validating or identifying targets using an in vivo system |
| 02/26/2004 | WO2003062401A3 Compositions and methods for the detection, diagnosis and therapy of hematological malignancies |
| 02/26/2004 | WO2003061583A3 Digenic mutations associated with severe insulin resistance and type 2 diabetes and their use in the diagnosis and treatment of diabetes |
| 02/26/2004 | WO2003060152A3 Alteration of restriction endonuclease specificity by genetic selection |
| 02/26/2004 | WO2003060111A3 Cancer-specific mutants of b-raf genes and uses thereof |
| 02/26/2004 | WO2003058193A3 Microarrays for cell phenotyping and manipulation |
| 02/26/2004 | WO2003057914A3 METHOD FOR DETECTING HUMAN PAPILLOMAVIRUS mRNA |
| 02/26/2004 | WO2003057845A3 Automated systems and methods for analysis of protein post-translational modification |
| 02/26/2004 | WO2003057014A9 Biomarkers for detecting ovarian cancer |
| 02/26/2004 | WO2003052141A3 High troughput analysis and detection of multiple target sequences using circular probes |
| 02/26/2004 | WO2003048386A3 Method for detection and quantitative analysis of nucleic acid molecules comprising an extraction step with a strong base and applications |
| 02/26/2004 | WO2003047420A3 Compositions and methods for detecting and treating diseases and conditions related to chemokine receptors |
| 02/26/2004 | WO2003046206A3 Polymorphism and haplotype scoring by differential amplification of polymorphisms |
| 02/26/2004 | WO2003046146A3 Compositions and methods of selective nucleic acid isolation |
| 02/26/2004 | WO2003046139A3 CRBs AS MODIFIERS OF BRANCHING MORPHOGENESIS AND METHOD OF USE |
| 02/26/2004 | WO2003043403A3 Methods and apparatus for blood typing with optical bio-discs |
| 02/26/2004 | WO2003039476A3 Methods and compositions for treating hematological disorders using 232, 2059, 10630, 12848, 13875, 14395, 14618, 17692 or 58874 |
| 02/26/2004 | WO2003035840A3 69583 and 85924, novel human protein kinase family members and uses therefor |